Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study - Trial NCT05447559
Access comprehensive clinical trial information for NCT05447559 through Pure Global AI's free database. This Phase 4 trial is sponsored by Monash University and is currently Not yet recruiting. The study focuses on Surgical Site Infection. Target enrollment is 9000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Monash University
Timeline & Enrollment
Phase 4
Sep 01, 2022
Jun 01, 2027
Primary Outcome
Incidence of surgical site infection
Summary
This multicentre, adaptive, pragmatic, double-blind, three-arm, placebo-controlled,
 randomised, non-inferiority clinical trial will compare the incidence of surgical site
 infection and other healthcare associated infections, health economic and microbiological
 impact after intraoperative only (Arm A), to 24 hours (Arm B) and, to 48 hours (Arm C) of IV
 cefazolin and placebo postoperative surgical antimicrobial prophylaxis in patients undergoing
 cardiac surgery
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05447559
Non-Device Trial